Publications by authors named "Virginia Naso"

Claim this Profile
C
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.
Caterina Alati, Martina Pitea, Matteo Molica, Luca Scalise, Gaetana Porto, Virginia Naso

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy.
Daniele Caracciolo, Filippo Antonio Canale, Virginia Naso, Caterina Alati, Violetta Marafioti

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CAR-T cell therapy in a patient with relapsed/refractory mantle cell lymphoma].
Virginia Naso, Filippo Canale, Giorgia Policastro, Gaetana Porto, Maria Pellicano

Recenti Prog Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of CAR-T treatment toward the potential risk of second malignancies.
Massimo Martino, Gaetana Porto, Giorgia Policastro, Caterina Alati, Barbara Loteta, Virginia Naso

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation.
Massimo Martino, Mercedes Gori, Gaetana Porto, Maria Pellicano, Ludovica Santoro, Virginia Naso

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.
Massimo Martino, Mercedes Gori, Gaetana Porto, Maria Pellicano, Ludovica Santoro, Virginia Naso

Ann Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Filippo A Canale, Massimo Martino, Gaetana Porto, Chiara Verduci, Giuseppe Console, Virginia Naso

Support Care Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?
Massimo Martino, Filippo Antonio Canale, Virginia Naso, Gaetana Porto, Demetrio Gerace

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
Massimo Martino, Virginia Naso, Barbara Loteta, Filippo Antonio Canale, Marta Pugliese

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Massimo Martino, Sebastiano Macheda, Umberto Aguglia, Luciano Arcudi, Giulia Pucci, Virginia Naso

Expert Opin Biol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.
Barbara Loteta, Annalisa Paviglianiti, Virginia Naso, Anna Ferreri, Tiziana Moscato

Support Care Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Massimo Martino, Filippo Antonio Canale, Caterina Alati, Iolanda Donatella Vincelli, Tiziana Moscato, Virginia Naso

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
Massimo Martino, Virginia Naso, Gaetana Porto, Annalisa Paviglianiti, Anna Ferreri

Transfus Apher Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
Massimo Martino, Mercedes Gori, Giovanni Tripepi, Anna Grazia Recchia, Michele Cimminiello, Virginia Naso

Ann Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34 Cell and Platelet Counts.
Massimo Martino, Mercedes Gori, Tiziana Moscato, Virginia Naso, Anna Ferreri

Biol Blood Marrow Transplant· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.
Massimo Martino, Marco Rossi, Anna Ferreri, Barbara Loteta, Antonella Morabito, Virginia Naso

Expert Rev Hematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Maria Christina Cox, Gerardo Musuraca, Roberta Battistini, Ivana Casaroli, Valerio Zoli, Virginia Naso

Br J Haematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
Massimo Martino, Sabino Ciavarella, Simona De Summa, Letteria Russo, Nicola Meliambro, Virginia Naso

Biol Blood Marrow Transplant· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Alessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, Benedetta Puccini, Caterina Patti, Virginia Naso

Haematologica· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
Caterina Tatarelli, Anna Lina Piccioni, Luca Maurillo, Virginia Naso, Roberta Battistini

Ann Hematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very long-lasting remission of refractory T-large granular lymphocytes leukemia and myeloma by lenalidomide treatment.
Sabrina Pelliccia, Arianna Di Napoli, Virginia Naso, Eleonora Alma, Caterina Rebecchini

Eur J Haematol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.
Maria Teresa Voso, Susanna Fenu, Roberto Latagliata, Francesco Buccisano, Alfonso Piciocchi, Virginia Naso

J Clin Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
Maria Christina Cox, Giuseppe Mannino, Luana Lionetto, Virginia Naso, Maurizio Simmaco

Am J Hematol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-lasting remission of a relapsed large cell non-Hodgkin's lymphoma by Y90 ibritumomab tiuxetan as salvage therapy.
Alessio Pio Perrotti, Pasquale Niscola, Sergio Boemi, Laura Scaramucci, Teresa Dentamaro, Virginia Naso

Tumori· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis